tiprankstipranks
Avalo Therapeutics announces first patient dosed in Phase 2 LOTUS trial
PremiumThe FlyAvalo Therapeutics announces first patient dosed in Phase 2 LOTUS trial
2M ago
Avalo Therapeutics trading resumes
Premium
The Fly
Avalo Therapeutics trading resumes
3M ago
Avalo Therapeutics trading halted, volatility trading pause
Premium
The Fly
Avalo Therapeutics trading halted, volatility trading pause
3M ago
Avalo Therapeutics appoints Doyle as Chief Medical Officer
PremiumThe FlyAvalo Therapeutics appoints Doyle as Chief Medical Officer
4M ago
Avalo Therapeutics announces active IND for AVTX-009
Premium
The Fly
Avalo Therapeutics announces active IND for AVTX-009
5M ago
Avalo Therapeutics Welcomes New Chief Legal Officer Paul Varki
Premium
Company Announcements
Avalo Therapeutics Welcomes New Chief Legal Officer Paul Varki
5M ago
Oppenheimer more bullish on Avalo Therapeutics, upgrades to Outperform
PremiumThe FlyOppenheimer more bullish on Avalo Therapeutics, upgrades to Outperform
7M ago
Avalo Therapeutics upgraded to Outperform from Perform at Oppenheimer
Premium
The Fly
Avalo Therapeutics upgraded to Outperform from Perform at Oppenheimer
7M ago
Avalo Therapeutics appoints Kantoff, Goldman, Truex as independent directors
Premium
The Fly
Avalo Therapeutics appoints Kantoff, Goldman, Truex as independent directors
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100